US2013109778A1PendingUtilityA1
Preparation of antimicrobial contact lenses with reduced haze using swelling agents
Assignee: JOHNSON & JOHNSON VISION CAREPriority: Mar 30, 2007Filed: Dec 20, 2012Published: May 2, 2013
Est. expiryMar 30, 2027(~0.7 yrs left)· nominal 20-yr term from priority
A61L 27/54G02B 1/043A61L 2300/104A61L 2300/404A61L 2300/106A61L 12/088A61L 2300/102
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
This invention relates to antimicrobial lenses containing metals and methods for their production.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 - 15 . (canceled)
16 . An antimicrobial lens comprising, a metal salt, made by a method comprise the steps of
(a) treating a cured lens, with a solution comprising salt precursor and a swelling agent, (b) treating the lens of step (a) with solution comprising a swelling agent for an appropriate time, and (c) treating the lens of step (b) with a solution comprising a metal agent and a swelling agent.
17 . The antimicrobial lens of claim 16 wherein the swelling agent is aqueous isopropanol, or aqueous propylene glycol.
18 . The antimicrobial lens of claim 16 wherein the swelling agent is about 30% to about 70% aqueous isopropanol.
19 . The antimicrobial lens of claim 16 wherein the swelling agent is 50% aqueous isopropanol.
20 . The antimicrobial lens of claim 16 wherein the swelling agent is aqueous propylene glycol.
21 . The antimicrobial lens of claim 16 wherein the salt precursor is selected from the group consisting sodium chloride, sodium iodide, sodium bromide, sodium sulfide, lithium chloride, lithium iodide, lithium bromide, lithium sulfide, potassium bromide, potassium chloride, potassium sulfide, potassium iodide, rubidium iodide, rubidium bromide, rubidium chloride, rubidium sulfide, caesium iodide, caesium bromide, caesium chloride, caesium sulfide, francium iodide, francium bromide, francium chloride, francium sulfide, and sodium tetrachloro argentate
22 . The antimicrobial lens of claim 16 wherein the salt precursor is sodium iodide.
23 . The antimicrobial lens of claim 16 wherein the metal agent is selected from the group consisting of silver nitrate, silver triflate, or silver acetate, silver sulfate, silver tetrafluoroborate, silver sulfate, zinc acetate, zinc sulfate, copper acetate, and copper sulfate.
24 . The antimicrobial lens of claim 16 wherein the metal agent is silver nitrate.
25 . The antimicrobial lens of claim 16 wherein the appropriate time is about 10 to about 40 seconds.
26 . The antimicrobial lens of claim 16 wherein the appropriate time is about 20 to about 30 seconds.
27 . The antimicrobial lens of claim 16 wherein one or more of the solutions of steps (a), (b), and (c) comprise a dispersing agent.
28 . The antimicrobial lens of claim 16 , wherein the dispersing agent is selected from the group consisting of polyvinylpyrrolidone, polyvinylalcohol and derivatives, glycerine, polyethylene oxide, poly(dimethyl acrylamide), poly(N-vinyl-N-methylacetamide), cysteine, methionine, sodium sulfide, sodium thiosulfate, and sodium thiocyanate.
29 . The antimicrobial lens of claim 16 wherein the dispersing agent is polyvinylpyrrolidone K90.
30 . The antimicrobial lens of claim 16 wherein the swelling agent is selected from the group consisting of extracting solvents as disclosed in U.S. Pat. No. 7,112,652.Join the waitlist — get patent alerts
Track US2013109778A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.